News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Remembering former ICR Chief Executive Professor Peter Garland
The ICR reflects on the legacy of Professor Peter Garland CBE, who served as Chief Executive from 1989 to 1999 and died on 5 March.
.png?sfvrsn=38d02ad6_1 "PW head and shoulders in garden_expand.jpg (1)")
The ICR’s Professor Paul Workman elected Fellow of the American Association of Cancer Research Academy
The Institute of Cancer Research, London, is delighted to announce that Professor Paul Workman has been elected as a Fellow of The American Association for Cancer Research (AACR) Academy.
New collaboration to advance innovative drugs for aggressive childhood brain tumours
Scientists at The Institute of Cancer Research, London, are partnering with Revolver Therapeutics to accelerate the development of pioneering drugs for treating incurable childhood brain tumours.
£1.5million funding boost to help unlock the genetic secrets of aggressive neuroblastoma
Scientists from The Institute of Cancer Research, London, will be part of a team of international researchers who have secured funding to study the genetic secrets of childhood cancer neuroblastoma.
.jpg?sfvrsn=999b1809_2 "Clinical trials pills bottles (16.9)")
Genetic factors likely to determine which patients will benefit from new prostate cancer combination therapy
Researchers have uncovered several biological signs that may determine how metastatic castration-resistant prostate cancer (mCRPC) responds to a new treatment combination.
Scientists develop new tool to beat cancer’s survival tactics
Scientists have developed a tool which helps them better understand cancer’s survival tactics – and could eventually lead to new treatments for dozens of cancer types.
The ICR welcomes London Growth Plan
The Institute of Cancer Research, London, is delighted to welcome the new London Growth Plan, launched by Mayor of London Sadiq Khan, which places life sciences at the forefront of an ambitious strategy to boost the capital’s economic growth.
New research might make an ‘undruggable’ target druggable – leading to new cancer drugs
Drug discovery researchers have made significant progress towards targeting a protein that is seen as a promising anticancer target but has, until now, been considered undruggable.
New AI model effectively predicts patient outcomes in a common type of lung cancer
Researchers have developed an artificial intelligence-based model that can help pathologists grade certain lung cancer tumours and predict patients’ outcomes.
Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering extended genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists from The Institute of Cancer Research, London.
Simple blood test could lead to smarter, kinder treatments for childhood cancers
Institute of Cancer Research scientists have developed a simple blood test that will help them better understand children’s cancers - and pave the way for new targeted and less toxic treatments.
-16-9.jpg?sfvrsn=b9495114_2 "Glioblastoma cells (Dr Chris Jones/the ICR) 16:9")
Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancer
Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma, a common type of adult brain tumour, rely on a specific enzyme for survival and that inhibiting this enzyme leads to the death of the cells.
